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Pulmonary emphysema is a progressive disease with airspace destruction and an effective
therapy is needed. Keratinocyte growth factor (KGF) promotes pulmonary epithelial
proliferation and has the potential to induce lung regeneration. The aim of this study was to
determine the possibility of using KGF gene therapy for treatment of a mouse emphysema
model induced by porcine pancreatic elastase (PPE). Eight-week-old BALB/c male mice
treated with intra-tracheal PPE administration were transfected with 80 μg of a recombinant
human KGF (rhKGF)-expressing FLAG-CMV14 plasmid (pKGF-FLAG gene), or with the
pFLAG gene expressing plasmid as a control, into the quadriceps muscle by electroporation.
In the lung, the expression of proliferating cell nuclear antigen (PCNA) was augmented, and
surfactant protein A (SP-A) and KGF receptor (KGFR) were co-expressed in PCNA-positive
cells. Moreover, endogenous KGF and KGFR gene expression increased significantly by
pKGF-FLAG gene transfection. Arterial blood gas analysis revealed that the PaO2 level was
not significantly reduced on day 14 after PPE instillation with pKGF-FLAG gene transfection
compared to that of normal mice. These results indicated that KGF gene therapy with
electroporation stimulated lung epithelial proliferation and protected depression of pulmonary
function in a mouse emphysema model, suggesting a possible method of treating pulmonary
emphysema.
Key words: keratinocyte growth factor, emphysema, elastase, electroporation, gene
therapy
I. Introduction
Chronic obstructive pulmonary disease (COPD) is an
increasing major public health problem that is characterized
by air flow limitation. COPD is projected to rank as the
third leading cause of death worldwide in 2020 and the
prevalence of this disease for adults over age 40 in Japan is
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10.9% [11, 33]. The mechanism of COPD has not been
elucidated, and treatment efficacy is poor except for lung
transplantation [15]. Regeneration medicine is a promising
therapy for COPD, and several COPD animal models
including an elastase-induced emphysema model have been
examined [13, 23, 42]. Since Massaro et al. suggested the
use of retinoic acid for elastase-induced pulmonary emphy-
sema in 1997 [23], various regenerative studies using reti-
noic acid [18, 39], adrenomedullin [29], hepatocyte growth
factor (HGF) [14, 36], granulocyte-colony stimulating fac-
tor (G-CSF) [17], basic fibroblast growth factor (bFGF)
[27], and simvastatin [37] have been reported.
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A strong alternative candidate for regeneration therapy
is keratinocyte growth factor (KGF) purified from the
conditioned medium of human embryonic lung fibroblasts
[9, 34]. KGF is a heparin-binding growth factor and a
fibroblast-derived mitogen. KGF selectively stimulates epi-
thelial cells through the keratinocyte growth factor receptor
(KGFR) that is expressed specifically on epithelial cells
[25]. KGF promotes the proliferation of alveolar type II
cells in vitro [31] and in vivo [40], and stimulates their
surfactant protein gene expression [6, 44]. Furthermore,
Morikawa et al. showed that adenoviral vector-mediated
KGF gene transfer stimulated alveolar type II cell prolifera-
tion [26]. In terms of therapeutic purposes, pre-treatment
with KGF before lung injury had protective effects on
bleomycin-induced lung injury [45], oleic acid-induced
lung injury [41], hyperoxia-induced lung injury [4], and
elastase-induced lung injury [32]. However, it is still
unclear whether KGF has a beneficial effect for post-
treated lung injury.
We have already reported that KGF augments lung
epithelial proliferation in the remaining lung after trilobec-
tomy following transfection by electroporation of a KGF-
expressing plasmid DNA in rats [24]. Kaza et al. were the
first to show that KGF enhanced compensatory lung growth
after pneumonectomy in rats [19]. We also previously
showed that administration of a KGF-expressing plasmid
using electroporation significantly enhanced compensatory
lung growth [24]. Moreover, exogenous KGF was shown to
augment lung epithelial cell proliferation and to decrease
the average airspace distance [12]. In terms of COPD
treatment, we therefore considered that KGF, which is
synthesized in different tissues far from the lung, may play
a beneficial role in lung repair or preventing progression of
emphysema.
In the present study, we investigated whether KGF
gene therapy, through transfection of the KGF gene into
muscles by means of electroporation, has a beneficial effect




Eight-week-old BALB/c male mice weighing 23–29 g
were purchased from SLC Japan (Shizuoka, Japan). The
mice were housed in an air-conditioned and light-controlled
room in the Biomedical Research Center, Center for Fron-
tier Life Sciences, Nagasaki University. The principles of
laboratory animal care (NIH publication No. 85-23, revised
1985) were followed. All experimental protocols were
approved by the Animal Research Committee of Nagasaki
University (No. 0601260487).
Pulmonary emphysema
Mice were anesthetized with 25 mg/kg sodium pento-
barbital (Dainippon Seiyaku Co., Tokyo, Japan) adminis-
tered intraperitoneally, and were intubated with a 24-gauge
intravenous catheter. Two units of porcine pancreas elastase
(PPE, Sigma Chemical Co., St. Louis, MO, USA) in 60 μl
saline were instilled intra-tracheally.
Plasmid DNA
Recombinant human KGF cDNA (kindly provided by
Jeffrey Rubin, National Cancer Institute, Bethesda, MD,
USA) was inserted between the BglII and XbaI restriction
enzyme sites of the p3×FLAG-CMV14 vector (Sigma) to
produce the pKGF-FLAG plasmid as reported previously
[24]. pFLAG was generated as a control vector. Plasmid
DNA was amplified in DH5α Escherichia coli, extracted
using the Plasmid Mega kit (QIAGEN, Venlo, Nether-
lands), and dissolved in TE buffer (10 mM Tris-HCl buffer
(pH 8.0) including 1 mM ethylenediaminetetraacetic acid
(EDTA)). DNA concentration was determined at a wave-
length of 260 nm using a UV photometer. KGF-FLAG pro-
tein expression from this plasmid was confirmed in vitro as
described below in enzyme-linked immunosorbent assays
using anti-KGF antibody and by Western blotting using
anti-FLAG antibodies [24].
Plasmid administration, electroporation, and tissue
preparation
For gene transfer, mice were electroporated at the
plasmid injection site using an Electro Square Porator
(T820; BTX Inc., San Diego, CA, USA). Immediately after
instillation of PPE, the bilateral quadriceps muscles were
denuded, and 40 μg of the pKGF-FLAG or the pFLAG
vector were injected once into each bilateral muscle. The
muscles were held by a pair of electrode disks (10 mm
in diameter and 5 mm apart) attached to tweezers (449-
10PRG; Meiwa Shoji, Tokyo, Japan), and electric pulses
were delivered. Six square wave pulses of 75 V were
administered for a duration of 20 ms at a rate of one pulse
per second. The mice were sacrificed at various time-points
after PPE administration with/without plasmid electropora-
tion and the lungs were dissected out. As an additional test,
plasmid was administered 4 days before PPE instillation to
establish the prophylactic effect of KGF. Each experimental
group consisted of 3 mice. The time scale of mouse treat-
ments and sacrifice is shown in Figure 1. Following
sacrifice, the lungs were fixed in 4% paraformaldehyde in
phosphate-buffered saline (PBS; pH 7.4) overnight and
embedded in paraffin. Serial sections 4-μm thick were cut
and stained with hematoxylin and eosin.
Antibodies
Polyclonal antibodies against KGF and KGFR were
prepared by immunizing rabbits with synthetic peptides
that were produced in cooperation with Nichirei Co.
(Tokyo, Japan) as previously described [43]. Anti-KGF IgG
(5 μg/ml) and anti-KGFR anti-serum (1:800) were used for
immunohistochemical analysis. Monoclonal mouse anti-
proliferating cell nuclear antigen (PCNA; 1.2 μg/ml) was
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purchased from DAKO (Glostrup, Denmark). Rabbit anti-
surfactant protein A (SP-A) polyclonal antibody (1:5000)
was purchased from Chemicon international (Temecula,
CA, USA). Horseradish peroxidase (HRP) conjugated
mouse monoclonal anti-FLAG antibody was purchased
from Invitrogen (Tokyo, Japan). Normal goat IgG, normal
rabbit IgG, and normal mouse IgG were purchased from
Sigma. Normal goat serum and normal rabbit serum were
purchased from DAKO. HRP conjugated goat anti-mouse
IgG, and HRP conjugated goat anti-rabbit IgG were pur-
chased from Chemicon International (Temecula, CA,
USA).
Biochemicals and chemicals
Bovine serum albumin (BSA), Triton X-100, Brij 35,
3-amino-9-ethylcarbazole (AEC), proteinase K, yeast
tRNA, salmon testis DNA, and dextran sulfate were pur-
chased from Sigma. 3,3'-diaminobenzidine/4HCl (DAB)
was purchased from Dojin Chemical Co. (Kumamoto,
Japan). Paraformaldehyde (PFA) was purchased from
Merck (Darmstadt, Germany). Biotin-16-dUTP and termi-
nal deoxynucleotidyl transferase (TdT) were purchased
from Roche (Mannheim, Germany). Blocking One was
purchased from Nacalai Tesque (Kyoto, Japan). ECL Plus
was purchased from Amersham Biosciences (Piscataway,
NJ, USA). All other reagents used in this study were pur-
chased from Wako Pure Chemicals (Osaka, Japan) and
were of analytical grade.
Measurement of KGF concentration and Western blotting
The concentration of human KGF in mouse lungs and
quadriceps muscle was measured using a KGF enzyme-
linked immunosorbent assay (ELISA) (DKG00; R&D
Systems, Minneapolis, MN, USA). The tissues were homo-
genized (SK-200; Funakoshi Co., Tokyo, Japan) and
diluted with a lysis buffer containing 50 mM Tris-HCl, 5
mM EDTA, 150 mM NaCl, 0.1 mM phenylmethylsulfonyl
fluoride (PMSF), and lima bean trypsin inhibitor. After
centrifugation, the supernatant was measured using an
ELISA kit. This supernatant was also used for Western blot-
ting of KGF. Samples were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis in a 4%–20%
gradient gel (Daiichi Pure Chemical, Tokyo, Japan). The
membranes were blocked with Blocking One for 0.5 hr
and were then reacted with HRP-conjugated anti-FLAG
antibody (1:6000) for 1 hr. After washing, the membranes
were visualized with the ECL Plus reagent [24].
Blood gas analysis
To assess pulmonary function, arterial blood gas was
analyzed using the i-STAT system (Brain Science Idea Co.,
Osaka, Japan). Blood samples were drawn from the
abdominal aorta under ventilation.
Immunohistochemistry
Immunohistochemical analysis of the expression of
KGF, KGFR, PCNA, and SP-A in lung tissues was per-
formed as previously described [1, 3, 38, 43]. Paraffin sec-
tions were dewaxed with toluene and rehydrated in serial
graded ethanol solutions. For KGFR detection, the sections
were pretreated with 0.2% Triton X-100 in PBS for 10 min
at room temperature. For KGFR and PCNA, the sections
were autoclaved at 120°C for 10 min in 10 mM citrate buf-
fer (pH 6.0). After inactivation of endogenous peroxidase
activity with 0.3% H2O2 in methanol for 30 min, the sec-
tions were preincubated with 500 μg/ml normal goat IgG
Protocol for mouse emphysema induction, gene transfection and mouse sacrifice. Emphysema was induced in mice by instillation of porcine
pancreas elastase (PPE). A plasmid encoding the FLAG-tagged keratinocyte growth factor (pKGF-FLAG), or control FLAG was electroporated into
quadriceps muscle either immediately post-PPE treatment (a), or pre-PPE treatment (b). Mice were sacrificed on the indicated days for analysis.
Fig. 1. 
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and 1% BSA in PBS (PCNA, SP-A), or 10% normal goat
IgG and 1% BSA in PBS (KGF, KGFR) for 1 hr to block
nonspecific reactions of the primary antibody. The sections
were then reacted with the primary antibodies for 2 hr
(KGF, KGFR) or overnight (PCNA, SP-A). After washing
with 0.075% Brij in PBS, the sections were incubated with
HRP-labeled goat anti-mouse or anti-rabbit IgG for 1 hr.
After washing with Brij, the HRP sites were visualized with
DAB and H2O2 solution, or with DAB, Ni, Co, and H2O2
solution. As a negative control, normal mouse IgG, normal
rabbit IgG, or normal rabbit serum was used instead of the
primary antibody. For colocalization of PCNA with KGFR
or SP-A, the sections were first reacted with anti-KGFR or
anti-SP-A antibody, and HRP sites were visualized with
DAB, Ni, Co, and H2O2 solution. The sections were then
immersed in 0.1 M glycine-HCl buffer (pH 2.2) for 90 min
and were then reacted with anti-PCNA antibody. HRP sites
were subsequently stained with AEC.
Terminal deoxynucleotidyltransferase-mediated dUTP
nick-end labeling (TUNEL) staining
TUNEL was performed to evaluate the presence of
apoptotic cells. Briefly, the sections were dewaxed with
toluene and rehydrated in serial graded ethanol solutions.
After washing with PBS, the sections were immersed in
proteinase K (1 μg/ml) for 15 min at RT, were rinsed with
distilled water, and were then reacted with 1× TdT buffer
(25 mM Tris-HCl buffer (pH 6.6) containing 0.2 M potas-
sium cacodylate and 0.25 mg/ml BSA) for 30 min at RT.
The slides were then reacted with 100 U/ml TdT dissolved
in a TdT buffer supplemented with 5 μM biotin-16-dUTP,
20 μM dATP, 1.5 mM CoCl2, and 0.1 mM dithiothreitol for
90 min at 37°C. Subsequently, the slides were washed with
0.05 M Tris-HCl buffer (pH 7.5) and immersed in 0.3%
H2O2 in methanol for 15 min. After incubation with 500
μg/ml normal goat IgG in 5% BSA in PBS for 1 hr, the
slides were reacted with HRP-goat anti-biotin antibody
(1:100) in 5% BSA in PBS overnight. The signals were
visualized with DAB, Ni, Co, and H2O2 solution [2, 22, 38].
In situ hybridization
In situ hybridization was performed as described
previously [21, 43]. Briefly, paraffin sections (6 μm in
thickness) were deparaffinized with toluene and rehydrated
using serially graded ethanol solutions. The slides were
immersed in 0.2 N HCl for 20 min and treated with pro-
teinase K (20 μg/ml) for 15 min at 37°C. After post fixa-
tion with 4% PFA in PBS for 5 min, the slides were
immersed twice in 2 mg/ml glycine PBS for 15 min and
then kept in 40% deionized formamide in 4× standard
saline citrate (SSC) until used for hybridization. Hybridi-
zation was carried out at 37°C with T-T dimerized antisense
KGF oligo-DNA (1 μg/ml) or KGFR oligo-DNA (1 μg/ml)
overnight in a medium containing 1 M Tris/HCl (pH 7.4),
5 M NaCl, 0.2 M EDTA, 100× Denhart’s solution, 10 mg/ml
yeast tRNA, 10 mg/ml salmon testis DNA, 50% dextran sul-
fate, 40% deionized formamide and 10 mM Tris/HCl-1mM
EDTA (pH 7.4). Preparation of oligo-DNA probes for KGF
and KGFR was described previously [21, 43]. After hybrid-
ization, the sections were washed 3 times with 50% form-
amide/2× SSC, then washed twice with 50% formamide/
0.5× SSC at 37°C for 1 hr per wash, and finally washed
twice with 2× SSC for 15 min per wash. The slides were
then incubated with blocking solution (500 μg/ml mouse
IgG, 5 M NaCl, 5% BSA, 100 μg/ml salmon testis DNA,
and 100 μg/ml yeast tRNA) for 1 hr at room temperature
and were then reacted with HRP-mouse anti-T-T antibody
(1:80) at RT overnight. After washing 4 times with 0.075%
Brij35 in PBS for 15 min, HRP sites were visualized with
DAB, Ni, Co, and H2O2 solution. Positive cells were deter-
mined using an image analyzer (DAB system; Carl Zeiss,
Thornwood, NY, USA), and were evaluated based on the
staining density divided by that obtained using the sense
probe (negative control). 28S rRNA was used as a positive
control to evaluate the hybridizable RNAs [43]. As control
experiments, the sections were hybridized with an antisense
probe in the presence of an excess amount of unlabeled
antisense probe to check on the diminished signals [20].
Quantitative analysis
For the quantitative analysis of PCNA expression, at
least 1,000 cells were counted in randomly selected fields.
The number of positive cells was expressed as a percentage
of positive cells per total number of counted cells (PCNA
labeling index (LI)) [24]. The signal densities of KGF,
KGFR, and SP-A were measured using an image analyzer
(DAB system) and were calculated as the sum of gray
values per area.
Statistical analysis
Data are expressed as mean standard deviation (SD).
Statistical differences between treatment groups were
examined by an unpaired t-test or a multiple comparison
test (Bonferroni/Dunn test, or Steel Dwass test). P values of
<0.05 were considered significant.
III. Results
KGF expression by rhKGF gene transfection into quadriceps
muscles
Expression of the KGF-FLAG protein in the quadri-
ceps muscle of electroporated mice was examined by West-
ern blot analysis using an anti-FLAG antibody. A specific
band corresponding to KGF-FLAG (28 kDa) was detected
on day 2 after pKGF-FLAG gene transfection (Fig. 2A).
The human KGF protein levels in the mouse quadriceps
and lung after pKGF-FLAG gene transfection were next
measured using an ELISA. The levels of KGF protein were
12200±125 pg/mg of tissue weight on day 3 and 1475±327
pg/mg of tissue weight on day 7 in the quadriceps muscles
(Fig. 2B), and 287±41.6 pg/mg of tissue weight on day 3
and 137±11.5 pg/mg of tissue weight on day 7 in the lung
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(Fig. 2C). KGF protein levels in the mice transfected
with the pFLAG gene were below measurable limits (<15
pg/ml) and endogenous KGF was not detected in the quad-
riceps and lung by ELISA. Therefore, changes in the KGF
protein level detected by ELISA definitely reflect changes
in the levels of the rhKGF protein. rhKGF expression in the
quadriceps and the lung had decreased by day 7 after
pKGF-FLAG gene transfection compared to day 3 after
transfection. These results may indicate that systemic
spreading of rhKGF was induced by pKGF-FLAG transfec-
tion into the leg muscles of mice.
Expression of KGF protein in mouse quadriceps muscle and
lungs. KGF-FLAG expression in mouse quadriceps muscle was ana-
lyzed by Western blotting using an anti-FLAG antibody on day 2 after
gene transfection of mice (A). The concentration of KGF in mouse
quadriceps muscle (B) and lungs (C) on day 3 and day 7 after gene
transfection was measured using an ELISA. * represents p<0.05 com-
pared to pFLAG control.
Fig. 2. 
Histological changes in lung emphysema after KGF gene
transfection
Initially, we characterized histological changes in the
lung resulting from KGF gene transfection by using a PPE-
induced emphysema model. In this model, as described pre-
viously, after intra-tracheal instillation of PPE, lung injury
with progressive alveolar wall destruction and enlargement
of air space was caused in a time-dependent manner.
Infiltration of inflammatory cells diminished gradually after
PPE instillation, and, by day 28 after PPE instillation,
emphysema was almost established and alveolar destruc-
tion was completed (Fig. 3A, B and C). As shown in Fig.
3D and E, KGF-FLAG gene transfection immediately after
PPE administration did not induce any changes in lung
morphological details compared to FLAG gene transfection
when analyzed three days after transfection.
KGF and KGFR expression in the emphysematous lung after
KGF gene transfection
We then immunohistochemically analyzed KGF and
KGFR levels in the lungs of non-treated mice and PPE-
treated mice. Endogenous KGF protein was detected in
alveolar and stromal cells in the lungs of non-treated mice
(Fig. 4A). In the 3-day PPE-treated lungs of mice whose
quadriceps muscles were transfected with pFLAG gene,
KGF expression in the lungs was almost equal to that of
non-treated mice (Fig. 4B). However, in the 3-day PPE-
treated lungs of mice whose quadriceps muscles were trans-
fected with the pKGF-FLAG gene, the KGF signal was
greatly increased after transfection compared to that of the
FLAG vector control (Fig. 4C and D). Quantitative analysis
of KGF signal density using an image-analyzer revealed
that the density of KGF in the lung of these pKGF-FLAG
gene-transfected mice was significantly increased to twice
the level of that in the pFLAG gene-transfected control
(pFLAG gene vs. pKGF-FLAG gene; 7.78%±3.37% vs.
15.09%±4.84% (pixel value/mm2), p=0.001) (Fig. 4G). In
contrast, expression of the KGFR in the PPE-treated lungs,
which was expressed in epithelial cells, did not change sig-
nificantly between the pFLAG gene- and pKGF-FLAG
gene-transfected mice (Fig. 4E, F and H).
Expression of KGF and KGFR mRNAs in mouse lung after
PPE instillation
We next performed in situ hybridization to examine
changes in the expression of KGF and KGFR mRNA in the
PPE-treated mouse lung. As shown in Fig. 5A and D, using
an anti-sense labeled probe, KGF mRNA was detected in
lung epithelial cells and macrophages on day 3 after PPE
instillation with FLAG gene transfection. This signal was
markedly increased on day 3 after PPE instillation with
pKGF-FLAG gene transfection (Fig. 5B and E). As a nega-
tive control, serial lung sections were hybridized with sense
probes, which resulted in no staining (data not shown).
When serial sections of the lungs of PPE-instilled, pKGF-
FLAG gene-transfected mice were hybridized with KGF
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Histological changes in mouse lung after instillation of PPE with or without KGF gene transfection. Lung tissues of mice treated PPE were fixed
on day 2 (A), day 7 (B), and day 28 (C) after instillation of PPE and were stained with hematoxylin and eosin. Alveolar wall destruction and air space
enlargement were seen in a time-dependent manner. Lungs of mice on day 3 after PPE instillation and transfection with the pKGF-FLAG gene (D) or
with the pFLAG gene (E) were similarly analyzed. Infiltration of inflammatory cells and hemorrhage were also seen in these tissues. Data are represen-
tative of 3 mice per group. Magnification: A, B and C (×40), Bar=200 μm; D and E (×200), Bar=100 μm.
Fig. 3. 
Immunohistochemical localization of KGF and KGFR proteins in mouse lung after PPE instillation with or without KGF gene transfection. KGF
protein expression in the mouse lung was immunohistochemically examined in a normal mouse (A), or on day 3 after PPE instillation into a mouse
transfected with the pFLAG gene (B) or the pKGF-FLAG gene (C and D). KGF was detected in alveolar cells and bronchial cells. The signal density of
KGF in the lungs of PPE-treated mice with KGF-FLAG gene transfection was significantly greater than that of PPE-treated mice with pFLAG gene
transfection (G). KGFR protein expression in the mouse lung was immunohistochemically examined on day 3 after PPE instillation with pFLAG gene
transfection (E) or with pKGF-FLAG gene transfection (F). KGFR signal density (H) was similar between (E) and (F). Data are representative of 3
mice per group. Magnification: A, B, C, E and F (×100), Bar=100 μm; D (×400), Bar=50 μm. * represents p<0.05.
Fig. 4. 
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antisense probes in the presence of a 100-fold excess
amount of unlabeled antisense oligo DNA, little signal was
detected, which confirmed the KGF specificity of the
hybridization reaction (Fig. 5C and F). Furthermore, a sig-
nal for KGFR mRNA was detected in the lungs of mice 7
days after PPE instillation with pFLAG gene transfection,
and this expression was significantly increased in the lungs
of mice 7 days after PPE instillation with pKGF-FLAG
gene transfection (Fig. 5G, H and I). These results indicated
that rhKGF-FLAG gene administration could enhance the
expression of both endogenous KGF and KGFR mRNA in
the injured lung. Therefore, the KGF protein that is pro-
duced in a remote site could be systemically delivered to
the lung.
Effect of KGF expression in quadriceps muscle on cell
proliferation, SP-A production, and apoptosis in mouse
lung instilled with PPE
We performed immunohistochemistry for PCNA to as-
sess the effect of pKGF-FLAG gene transfection on the pro-
liferation of lung cells in the mouse emphysema model.
The number of PCNA-positive cells in the lung increased on
day 2 (LI=11.95%±3.94%) and day 3 (LI=14.60%±4.38%)
after PPE instillation in control mice transfected with the
pFLAG gene (Fig. 6A and C). When PCNA levels in the
lungs of PPE-instilled mice with pKGF-FLAG gene trans-
fection were compared to those of pFLAG gene-transfected
PPE-treated mice, the number of PCNA-positive cells
was significantly increased on day 2 (LI=13.90%±4.84%),
and further increased on day 3 (LI=19.50%±4.52%) (Fig.
6B, D and E). Subsequently, the number of PCNA-positive
cells had decreased by day 7 (LI=7.95%±2.19% with
pFLAG gene transfection, LI= 8.95%±2.80% with pKGF-
FLAG gene transfection). PCNA-positive cells were iden-
tified as alveolar epithelial cells, bronchial epithelial cells,
endothelial cells and macrophages. To evaluate the effect
of the pKGF-FLAG gene in more detail, we performed
immunohistochemistry for SP-A, which was used as a
marker of alveolar type II epithelial cells. Staining for SP-A
was significantly increased on day 3 in the lungs of PPE-
In situ localization of KGF and KGFR mRNA in the mouse lung after PPE instillation with or without KGF gene transfection. KGF and KGFR
mRNAs were analyzed in mouse lung sections by in situ hybridization on day 3 and day 7, respectively after PPE instillation with pFLAG or pKGF-
FLAG gene transfection. (A–F): Sections of lung from mice 3 days after PPE instillation and transfection with the pFLAG gene (A) or the pKGF-FLAG
gene (B) were hybridized with a KGF antisense probe. These slides were further analyzed using an image analyzer that applied pseudo color to the
specific signal (D and E, respectively). A section from mice PPE-treated and transfected with the pKGF-FLAG gene was hybridized with a KGF anti-
sense probe in the presence of an excess amount of unlabeled antisense probe (C) and the same slide was subjected to image-analysis (F). (G–I): Lung
sections from mice 7 days after PPE instillation and transfection with the pFLAG gene (G) or the pKGF-FLAG gene (H) were hybridized with a KGFR
antisense probe and the signal density was analyzed (I). The signal density of the KGFR in the lung section with pKGF-FLAG gene transfection was
significantly greater than that with pFLAG gene transfection (I). Magnification: ×100, Bar=100 μm. * represents p<0.05.
Fig. 5. 
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instilled mice with pKGF-FLAG gene transfection, com-
pared to that of PPE-instilled mice with pFLAG gene
transfection (p=0.002) (Fig. 6F, G and H). When we per-
formed double-staining for PCNA and SP-A or KGFR on
day 3 after PPE instillation with pKGF-FLAG gene trans-
fection, colocalization of PCNA and SP-A was detected in
alveolar type II cells (Fig. 6I), and colocalization of PCNA
and KGFR was detected in alveolar epithelial cells (Fig.
6J). TUNEL staining was also performed to assess apopto-
sis due to lung injury. As shown in Fig. 7A, B and C, there
was no significant difference in the number of apoptotic
cells in the emphysematous lung between mice with or
without KGF gene at day 3.
KGF gene transfection protected gas exchange function in
the emphysematous lung
To confirm the effectiveness of KGF gene transfection
as a gene therapy, we analyzed gas exchange function in
the PPE-treated emphysema lung with FLAG gene or with
KGF-FLAG gene transfection and compared it to that of
normal non-treated mice. As shown above (Fig. 3D and E),
there was essentially no difference in lung morphological
details between PPE-instilled mice transfected with pFLAG
and those transfected with pKGF-FLAG on day 3 after
transfection. However, when we analyzed arterial blood gas
as an indicator of pulmonary function, the PaO2 level on
day 14 after PPE administration and KGF-FLAG gene
Immunohistochemical staining of proliferation cell nuclear antigen (PCNA) and surfactant protein A (SP-A) in mouse lung after PPE instillation
with or without KGF gene transfection, and double immunohistochemical staining for PCNA and SP-A or KGFR in mouse lung on day 3 after PPE
instillation with KGF gene transfection. (A–E): PCNA-positive cells were detected immunohistochemically in the lungs of mice on day 2 (A) and day 3
(C) after PPE instillation with pFLAG gene transfection, and on day 2 (B) and day 3 (D) after PPE instillation with pKGF-FLAG gene transfection. The
PCNA labeling index (LI) for day 2, 3 and 7 was calculated (E). (F–H): SP-A expression in the lungs of mice was detected immunohistochemically on
day 3 after PPE administration with pFLAG gene transfection (F) or with pKGF-FLAG gene transfection (G). SP-A signal density was measured with
an image-analyzer (H). (I, J): Co-localization of PCNA with SP-A (I) or KGFR (J) was immunohistochemically analyzed. PCNA (red) was detected in
the nucleus and SP-A (black) was detected in the cytoplasm of alveolar epithelial cells (I). PCNA (red) was detected in the nucleus and KGFR (black)
was detected in the cytoplasmic membrane of alveolar epithelial cells (J). Black arrows (PCNA) and open white arrows (SP-A or KGFR) point to cells
with co-localized proteins. Magnification: A, B, C, D, F and G (×100), Bar=200 μm; I and J (×200), Bar=200 μm. * represents p<0.05.
Fig. 6. 
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treatment was nearly comparable to that of normal lung,
while the PaO2 level in the emphysema mice with the trans-
fected pFLAG gene was significantly lower than that of
normal lung (Fig. 8A). Of note, the PaO2 level on day 7
after PPE instillation of mice that were pre-treated with
KGF gene transfection 4 days prior to PPE instillation was
almost the same as that of normal mice, demonstrating the
protective effect of KGF gene therapy. There were no
significant differences in PaCO2 levels between the PPE-
instilled mice treated with and without KGF gene transfec-
tion (Fig. 8B).
IV. Discussion
In the present study, we investigated whether KGF
gene transfection into the skeletal muscles by means of
electroporation could be a therapeutic tool in terms of
preventing the progression for the emphysematous lung.
Although there have been a number of reports regarding the
protective effect of KGF pre-treatment in lung injury
models, there have only been a few reports describing bene-
ficial KGF post-treatment for lung injury. Sakamoto et al.
showed that intratracheal administration of a KGF-
expressing adenoviral vector improved respiratory function
and mortality in bleomycin-induced pulmonary fibrosis
[35]. Yildirim et al. reported that oropharyngeal aspiration
of the KGF protein promoted lung regeneration in elastase-
induced emphysema [46]. However, the most appropriate
route of administration of KGF for lung repair and regener-
ation remains unknown in these lung injury models. Here,
we have shown that KGF produced in remote muscle tissue
by transfection of the muscle with the pKGF-FLAG gene
successfully promoted alveolar cell proliferation. More-
over, even post-injury treatment with pKGF-FLAG gene
transfection resulted in the improvement of lung function in
a PPE instillation mouse emphysema model.
We demonstrated that the expression of KGF and
the number of PCNA-positive cells were significantly
increased in the lung on day 3 after PPE instillation with
pKGF-FLAG gene transfection compared to those in the
lung after PPE instillation and transfection with pFLAG
gene. SP-A and KGFR were co-expressed in some prolifer-
ating cells, indicating that exogenous rhKGF protein as
well as endogenous KGF stimulated cell proliferation, in
particular, of pulmonary type II cells through the KGFR.
Moreover, we examined the expression of KGF mRNA in
TUNEL staining in mouse lung after PPE instillation with or without KGF gene transfection. (A–C): Sections of mouse lung on day 3 after PPE
instillation and gene transfection with the pFLAG gene (A) or with the pKGF-FLAG gene (B) were analyzed for apoptosis by TUNEL staining. The
number of TUNEL-positive cells was similar between the two groups (C). Magnification: ×200, Bar=100 μm.
Fig. 7. 
Arterial blood gas analyses in mouse emphysema lung with or without KGF gene transfection. Mice were not transfected and not treated (normal)
or were transfected with the pKGF-FLAG gene 4 days prior to PPE instillation (Pre-KGF), or were transfected with the pFLAG gene (control) or the
pKGF-FLAG gene immediately after PPE instillation and the values of arterial PaO2 and arterial PaCO2 (A and B, respectively) were assessed on the
subsequent indicated days. The PaO2 level of mice on day 14 after PPE instillation with the pFLAG gene was decreased compared to normal mice. In
contrast, the PaO2 level of mice on day 14 after PPE instillation with the pKGF-FLAG gene and that of mice pretreated with KGF before PPE instilla-
tion for 7 days was comparable to that of normal lung. * represents p<0.05.
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the lung by in situ hybridization, and we detected expres-
sion of KGF mRNA on day 2 after pKGF-FLAG gene
transfection (data not shown); it was markedly increased by
day 3. It is not known whether exogenous KGF induces up-
regulation of endogenous KGF, however it is indicated the
potential for a KGF-dependent autocrine loop in pancreatic
cancer [16]. Chedid et al. reported that proinflammatory
cytokines up-regulated KGF gene expression and protein
levels in fibroblasts from multiple sources [5], and Yildirim
et al. reported that rhKGF induced proliferation of fibro-
blasts in emphysematous mice [46]. Furthermore, Niu et al.
reported that KGF induced NF-kappaB activation, and
stimulated the expression of NF-kappaB regulated genes
such as IL-1 [30]. The mechanism of KGF up-regulation
in this animal model is unknown, however these results
strongly indicate that pKGF-FLAG gene transfection of
skeletal muscle by electroporation provided rhKGF protein
into the lung, and that this rhKGF might up-regulate the
endogenous synthesis of KGF in the lung.
Emphysema is recognized as a progressive disease
with a combination of long-term inflammation, oxidative
stress, and protease-anti protease imbalance with alveolar
wall destruction [33]. In the elastase-induced emphysema
model that was used here, intra-tracheal elastase instillation
was previously shown to induce hemorrhage and an early
inflammatory exudate with neutrophils and macrophages,
resulting in the destruction of the alveolar wall due to apo-
ptosis [10]. Mouded et al. reported that airspace enlarge-
ment progressively continued in this animal model
throughout the 21 days monitored after elastase instillation
[28]. Thus, the behavior of this model seems to have some
similarity with human emphysema. In the present study,
arterial blood gas examination indicated that the PaO2 level
was on the rise again by day 14 in the lungs of mice trans-
fected with the pKGF-FLAG gene, although no improve-
ment in anti-apoptotic effect or inhibition of airspace
destruction was observed on day 3 after PPE instillation
and gene transfection. Plantier et al. reported that KGF pre-
treatment in this model reduced the number of TUNEL-
positive cells [32]. They administered KGF on day 3 before
PPE instillation, and TUNEL staining was performed on
day 7 after PPE instillation. Although it is difficult to make
a direct comparison between their results and our results
because of the different times of KGF administration, the
different times of evaluation may contribute to the different
results obtained.
Regarding the method of KGF administration, KGF
gene transfection appears to be a useful alternative method
to direct injection of recombinant human KGF protein.
Although single instillation of the KGF protein should, in
theory, be the simplest method of administering KGF, the
effect of such instillation was reported to diminish within
only a few days [8]. Gene therapy has advantages over
intra-tracheal administration of the KGF protein in terms of
prolonged protein expression and low cost [41]. For these
reasons, we utilized gene transfer by electroporation to effi-
ciently transfect the gene at a specific site and to make
repetitive administration easy. In addition, plasmid DNA
was injected into bilateral quadriceps muscle to avoid lung
damage by gene transfection without general anesthesia.
Gene transfection by electroporation is considered to be a
safe and simple method that requires only a low dose of
DNA without virus-associated adverse effects. However,
there is some controversy surrounding the use of this
method because of the lower levels of protein expression
obtained compared to the use of viral vectors or of direct
intra-tracheal administration of protein. Yildirim et al.
reported that intra-tracheal multicycle application of 10 mg
KGF protein/kg body weight was necessary to achieve a
maximal proliferative response in alveolar type II epithelial
cells in the elastase-induced emphysema model [46]. On
the other hand, Furukawa et al. reported that the repeated
administration of a low dose of KGF (0.4 mg/kg) gave the
same effect as that of administration of a high dose (4
mg/kg) [12]. Currently, the optimal treatment threshold for
the gene transfer method using electroporation in this ani-
mal model is unclear, because of differences in the route of
administration and the absorption efficiency in the different
studies. In our previous study, we showed enhanced alveo-
lar septation and an increased number of alveoli on day 7
after pKGF-FLAG gene transfection in the trilobectomy rat
model, in spite of the short duration of rhKGF expression,
which had returned to the control level on day 7 after gene
transfection [24]. Based on these reports, it seems likely
that repeated gene transfection into skeletal muscle by
electroporation has the potential to provide sufficiently ef-
fective treatment, even though KGF production by a single
gene transfection is low.
In the present study, rhKGF expression in the quadri-
ceps and lungs was detected on day 3 and, although it had
decreased by day 7, it was still detectable and at a higher
level than KGF protein expression in control mice trans-
fected with the pFLAG gene. On the other hand, KGFR
expression in the lung was not significantly enhanced on
day 3 following KGF gene transfection, although co-
expression of the KGFR and PCNA in alveolar type II epi-
thelial cells was detected in these cells. Interestingly, the
expression of endogenous KGFR mRNA in the lung had
increased by day 7 after KGF gene transfection and PPE
instillation and was higher than that in pFLAG gene-
transfected cells. The mechanism of increasing KGFR
expression is still unknown. D’Amici et al. reported that
proinflammatory cytokines up-regulated FGFR2mRNA
expression and gene transcription in epithelial or mesen-
chymal cells [7], however there have been very few reports
about regulation of KGFR expression. Thus, expression of
the KGFR as well as that of KGF might be up-regulated by
transfection of the pKGF-FLAG gene. Therefore, we would
like to propose that KGF gene therapy that is accompanied
by lung epithelial cell proliferation has potential as a thera-
peutic tool for lung emphysema.
In conclusion, our results indicated that KGF gene
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administration into skeletal muscles by electroporation in a
mouse emphysema model enhanced the proliferation of
lung epithelial cells, and relieved prolonged hypoxia.
Although further work is clearly needed to apply this
approach for the treatment of COPD, we believe that these
findings support a future approach aimed at establishing
gene therapy as a method for induction of lung regenera-
tion.
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